KIR3DL2 and synovial sarcoma: Expression of KIR3DL2 detected by the Q66 mAb was initially demonstrated in the former cell lines and further confirmed on the corresponding patient’s primary circulating cells and extended to seven other SS patients and to the skin of two patients with advanced MF (56).